Trial Profile
Evaluation of the Effect of Gemigliptin on Metabolic Endotoxemia and Lipemia Induced by High Fat Diet in Patients With Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Gemigliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 20 Apr 2016 Placebo added to treatment table.
- 20 Apr 2016 Status changed from not yet recruiting to completed.
- 16 Jul 2014 New trial record